BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32370941)

  • 21. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
    Tutu EO; Lawson B; Browne E
    Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso.
    Zango SH; Lingani M; Valea I; Samadoulougou OS; Bihoun B; Rouamba T; Derra K; Rouamba E; Donnen P; Dramaix M; Tinto H; Robert A
    PLoS One; 2020; 15(11):e0242368. PubMed ID: 33196665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria Case Fatality Rate among Children under Five in Burkina Faso: An Assessment of the Spatiotemporal Trends Following the Implementation of Control Programs.
    Ouédraogo M; Kangoye DT; Samadoulougou S; Rouamba T; Donnen P; Kirakoya-Samadoulougou F
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32178354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].
    Ouédraogo A; Bougouma EC; Diarra A; Konaté AT; Nébié I; Tiono AB; Sirima SB
    Med Mal Infect; 2008 Apr; 38(4):180-6. PubMed ID: 18262380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
    Chico RM; Chandramohan D
    Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Malawi.
    Rubenstein BL; Chinkhumba J; Chilima E; Kwizombe C; Malpass A; Cash S; Wright K; Troell P; Nsona H; Kachale F; Ali D; Kaunda E; Lankhulani S; Kayange M; Mathanga DP; Munthali J; Gutman JR
    Malar J; 2022 Jun; 21(1):195. PubMed ID: 35729612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.
    Müller O; Traore C; Kouyate B
    Malar J; 2004 May; 3():10. PubMed ID: 15134583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
    Andronescu LR; Sharma A; Peterson I; Kachingwe M; Kachepa W; Liang Y; Gutman JR; Mathanga DP; Chinkhumba J; Laufer MK
    J Infect Dis; 2022 Jan; 225(2):248-256. PubMed ID: 34216212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
    ter Kuile FO; van Eijk AM; Filler SJ
    JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO; Bisaso RK; Byamugisha J; Obua C
    Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors of malaria and anaemia and the impact of preventive methods among pregnant women: A case study at the Akatsi South District in Ghana.
    Ahadzie-Soglie A; Addai-Mensah O; Abaka-Yawson A; Setroame AM; Kwadzokpui PK
    PLoS One; 2022; 17(7):e0271211. PubMed ID: 35877761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.
    Doumbia I; Seydou F; Diakalia K; Bennis I
    Malar J; 2021 Oct; 20(1):402. PubMed ID: 34656113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
    Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.